InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

NASDAQ:NVIV

InVivo Therapeutics Holdings Corp.

Last Close

0.49

12/02 21:00

Market Cap

995.92K

Beta: 0.82

Volume Today

1.61M

Avg: 100.11K

PE Ratio

−0.09

PFCF: −0.08